1. Home
  2. CTMX vs ALRS Comparison

CTMX vs ALRS Comparison

Compare CTMX & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.39

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

HOLD

Current Price

$21.78

Market Cap

536.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
ALRS
Founded
2008
1879
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
536.4M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
CTMX
ALRS
Price
$4.39
$21.78
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$6.50
$25.00
AVG Volume (30 Days)
2.8M
87.8K
Earning Date
11-06-2025
01-27-2026
Dividend Yield
N/A
3.86%
EPS Growth
50.22
1114.87
EPS
0.24
1.95
Revenue
$113,631,000.00
$275,452,000.00
Revenue This Year
N/A
$43.58
Revenue Next Year
N/A
$3.26
P/E Ratio
$18.32
$11.13
Revenue Growth
N/A
67.44
52 Week Low
$0.40
$15.78
52 Week High
$4.62
$24.33

Technical Indicators

Market Signals
Indicator
CTMX
ALRS
Relative Strength Index (RSI) 61.95 40.27
Support Level $3.86 $21.93
Resistance Level $4.37 $23.66
Average True Range (ATR) 0.26 0.51
MACD 0.02 -0.17
Stochastic Oscillator 90.71 2.99

Price Performance

Historical Comparison
CTMX
ALRS

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: